National Institutes of Health

Psychology & Psychiatry

Ketamine cousin rapidly lifts depression without side effects

GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the street drug side effects, reported a study funded by the National Institute of Mental Health (NIMH) that was published last month ...

Alzheimer's disease & dementia

New memory drug moves into Phase 1 clinical study

An experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with support from the NIH Blueprint Neurotherapeutics Network, ...

Neuroscience

Study finds multiple sclerosis drug slows brain shrinkage

Results from a clinical trial of more than 250 participants with progressive multiple sclerosis (MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study also showed that the main side ...

Psychology & Psychiatry

Study finds out why some words may be more memorable than others

Thousands of words, big and small, are crammed inside our memory banks just waiting to be swiftly withdrawn and strung into sentences. In a recent study of epilepsy patients and healthy volunteers, National Institutes of ...

HIV & AIDS

Brain cells can harbor and spread HIV virus to the body

Researchers have found that astrocytes, a type of brain cell can harbor HIV and then spread the virus to immune cells that traffic out of the brain and into other organs. HIV moved from the brain via this route even when ...

Neuroscience

Brain recalls old memories via new pathways

People with anxiety disorders, such as post traumatic stress disorder (PTSD), often experience prolonged and exaggerated fearfulness. Now, an animal study suggests that this might involve disruption of a gradual shifting ...

page 7 from 40